Learn the importance of identifying systemic and localized Type 2 inflammation in your patients with moderate-to-severe, uncontrolled asthma. In this event, an expert...

​Please join Amgen and AstraZeneca as they share a different approach that may shift your point of view. Our expert will cover the efficacy and safety data and how it...

Please join Steven Nathan, MD, FCCP, as he discusses the current state of OFEV, including recent guideline updates. Dr. Nathan will discuss the safety and efficacy of...

This webinar will cover clinical trial data and the latest real-world evidence for treating severe eosinophilic asthma with a targeted biologic treatment.

Please join Amgen and AstraZeneca as they share a different approach that may shift your point of view.

Will discuss combining multiple procedures (EBUS-TBNA, Navigated Peripheral Bronchoscopy, and Navigated-Percutaneous Biopsy) into one in a single care setting within...

Adempas for Pulmonary Arterial Hypertension associated with Congenital Heart Disease: Data from Patent-1 subgroup

This session will discuss key considerations for the diagnosis of patients with Interstitial Lung Disease (ILD) and provide a review on how to incorporate the Envisia...

Experts in non-cystic fibrosis bronchiectasis (NCFB) will discuss current challenges in diagnosis and management, characterization of disease severity, and emerging...

This virtual learning session will review the clinical data from a recent Phase IV study.

This presentation will provide an overview of chronic fibrosing interstitial lung diseases (ILDs), with a focus on those with progressive phenotypes. Expert faculty...

In this programme, divided into four segments, viewers will learn about the pathophysiology, diagnosis, clinical complications associated with EGPA, and...

This virtual learning session will review the clinical data from a recent Phase IV study. This program is sponsored by Bayer Healthcare.

This webinar provides an overview of a Remote Patient Monitoring solution developed by Dr. Gerald Criner and colleagues at Temple University to efficiently monitor and...

This virtual learning session will review the clinical data from a recent Phase IV study.

There’s a new way to think about asthma, and it starts at the top of the inflammatory cascade. Join us 12/6/21 at 12pm ET for an interactive, case-based discussion...

Please join Dr. Fariborz Rezai as he discusses the advancements of single-use bronchoscopy and their clinical application across various patient profiles and sites of...

This program will provide a comprehensive look at proning including the latest evidence and practical applications of proning patients on various levels of respiratory...

This virtual learning session will review the clinical data from a recent Phase IV study.

Dr. Goldman will provide an overview of the current treatment landscape for patients who have been hospitalized with COVID-19 as recommended by the NIH COVID-19...

This activity will explore evidence-based strategies for the diagnosis, evaluation, and treatment of NTM-LD and help clinicians individualize treatment selection and...

There’s a new way to think about asthma and it starts at the top of the inflammatory cascade. Join us on October 12th at 6:30 p.m. as two experts explore the role of a...

This program will review safety and efficacy data supporting the use of a biologic as a treatment for patients with severe eosinophilic asthma or CRSwNP.

Join Dr. Tanzira Zaman from Cedars-Sinai Medical Center in Los Angeles, CA, as she reviews background information followed by an overview of the OFEV pivotal safety...

The clinical use of multiplex PCR platforms, like the BioFire® FilmArray® Pneumonia (PN) Panel, in CAP patients dramatically increases the frequency of detection of...

This virtual learning session will review the clinical data from a recent Phase IV study.

In this Webinar, the faculty will review the signs, symptoms, laboratory, histopathologic, and image findings that lead to better diagnosis of uILD, review their...

The webinar will review the the ESICM Clinical Practice Guidelines (Rochwerg, 2020) recently published in Intensive Care Medicine, regarding the use of Nasal High Flow...

This will be a pre-recorded video with Professor Howarth narrating the slide deck and providing insight/context to the data. After the video has been played, he will...

Hear Dr. Janani Reisenauer, Dr. Ganesh Krishna and Dr. Sebastian Fernandez-Bussy examine how to demystify new robotic technologies. While reviewing patient cases, they...

With the arrival of new sleep apnea treatment options, differentiating CSA vs OSA is crucial to establishing the treatment plan. Phrenic nerve stimulation, hypoglossal...

In this Webinar, the faculty will review the signs, symptoms, laboratory, histopathologic, and image findings that lead to better diagnosis of uILD, review their...

Learn about PUG: the next advancement in the shift to bedside procedural care. Join us for a discussion of ultrasound gastrostomy, current practice, and experience...

Respiratory specialists around the world are now adapting to virtual models of care for their patients. These models offer significant opportunities for data driven...

The current landscape of lung nodule assessment can benefit from more objective tools in determining the risk of malignancy. The Percepta Nasal Swab is a novel genomic...

An interdisciplinary look at the implementation of Nasal High Flow across the hospital setting to improve patient flow, reduce escalation, and preserve ICU beds.

Join us for a presentation focused on an investigational therapy that may rebalance BMPR-II/activin receptor signaling.

Boehringer Ingelheim is pleased to bring you a stimulating discussion featuring experts, Donald Mahler, MD and Jill Ohar, MD.

This Innovation Theatre is intended to educate attendees on the current management of COVID-19 patients in the outpatient and critical care setting. Attendees will...

Join Dr. Shambhu Aryal as he reviews background information followed by an overview of the OFEV pivotal safety and efficacy data. This presentation is made on behalf...

A goal of asthma treatment is to achieve and maintain asthma control. However, uncontrolled asthma remains common and often goes unrecognized by patients and...

MONARCH® Platform Programs In An Academic & Community Setting. Drs. D. Kyle Hogarth and Susan Garwood share their firsthand experience using MONARCH®, the first...

Speakers will discuss the gaps in the lung cancer diagnosis and care continuum and the transformative role of novel genomic tests, such as a non-invasive nasal swab...

This presentation will provide an overview of chronic fibrosing interstitial lung diseases (ILDs), with a focus on those with progressive phenotypes. Expert faculty...

There’s a new way to think about asthma and it starts at the top of the inflammatory cascade. Join us as two experts explore the role of a key epithelial cytokine,...

Join Dr. Nathanael Brady as he explores recent clinical evidence supporting the use of triple therapy for the maintenance treatment of adult patients with Asthma or...

Understanding of the determinants of ventilation defects and ventilation heterogeneity may lead to more efficacious treatments for acute and chronic lungs diseases and...

Join Shyam Subramanian, MD FCCP, on February 17, 2021 at 6:30 pm as he discusses the diagnosis and management of systemic fungal infections and shares how advanced...

This webinar will explore the mechanism of action of Nasal High Flow and the clinical evidence for use before and during the COVID-19 pandemic. Evidence for the use of...

This program will cover the epidemiology of the current COVID-19 pandemic and show where demographic disparities exist. Information on the clinical trials, efficacy...

An informative, non-CME, virtual disease state presentation focusing on nasal polyposis and airway comorbidities. This presentation will familiarize viewers with the...

Join Drs. Gregory Cosgrove and Jonathan Chung as they discuss the HRCT features and patterns associated with a progressive phenotype in patients with chronic fibrosing...

This virtual learning session will review the clinical data from a recent Phase IV study looking at a treatment paradigm in the management of adult patients with PAH

Join us for a presentation focused on a new potential therapy that may change the course of PAH progression by rebalancing BMPR2 signaling.

This interactive session covers the key elements of an MDD, the role of the Envisia genomic classifier, and the identification of progressive fibrosing ILD.

This program will provide an overview on chronic fibrosing interstitial lung diseases (ILDs), with specific examples of those with progressive phenotypes. Expert...

Eosinophils are increasingly being recognized as important in the pathophysiology of various airway diseases and an important cell type in disease endotypes. This...

Nebulization safety in the COVID-19 era has been challenged due to concerns regarding transmissibility of the virus via nebulizer. Join International expert Rajiv...

A Path to Asthma Control: DUPIXENT® (dupilumab) Is the Only Biologic Indicated for OCS-Dependent Asthma

This expert-led event will include a review and discussion of clinical and real-world data evaluating a biologic treatment to help reduce exacerbations and maintenance...

Are you up to date on the newest developments in Asthma and COPD maintenance treatment options? Join Dr. Ravi Kalhan review the latest clinical evidence supporting the...

There’s a new way to think about asthma and it starts at the top of the inflammatory cascade. Join us as an expert explores the role of a key epithelial cytokine,...

Has COVID-19 impacted the way you treat your COPD patients?

The program will review background information followed by the most up-to-date data supporting the efficacy and safety of OFEV. The presentation is sponsored by...

A static image can make nodule biopsies using lung navigation challenging. You need confidence throughout the procedure to know you are on target. Learn about the...

An informative, non-CME, disease state virtual presentation focusing on chronic rhinosinusitis with nasal polyps (CRSwNP).

Join us for a presentation focused on a new potential therapy that may change the course of PAH progression by rebalancing BMPR2 signaling.

With the GOLD 2020 strategy document, the focus on utilization of the treatable traits approach of symptoms and exacerbations for COPD management continues to gain...

Respiratory Specialists are now rapidly adapting their models of care in light of COVID-19. What are the best practices for remote monitoring of respiratory patients?...